Industry Briefing
A single destination for timely, editor-curated robotics news from around the world.
Subsense Expands AI-Driven Nanoparticle Brain-Computer Interface Strategy Without Surgery
Subsense, an AI-native neurotechnology company, has announced a significant expansion of its NanoBCI strategy, which focuses on non-surgical, nanoparticle-based brain-computer interfaces (BCIs). This innovative approach aims to read or stimulate neural activity without the need for permanently implanted electrodes, setting it apart from traditional BCI methods that rely on invasive hardware or external neural activity capture. The development of the first AI-native NanoBCI is crucial as it integrates AI into the entire design process, from nanoparticle candidate evaluation to modeling their navigation within the brain. By utilizing AI upstream, Subsense aims to optimize the design of the interface itself, enhancing the effectiveness of the materials and delivery mechanisms involved in the BCI technology. Looking ahead, Subsense has received $250,000 in Google Cloud credits to further enhance its computational workflows and expand its nanoparticle design exploration. This funding will support the company's efforts to refine its AI infrastructure, ultimately aiming to challenge the existing trade-offs in the BCI field regarding signal quality and surgical intervention.
Computing Engineering News artificial intelligence bci brain technology
Tianjin University Launches China's First Doctoral Program in Brain-Computer Interface
Tianjin University has been officially approved for China's first doctoral program in Brain-Computer Interface (BCI), marking a significant milestone in the development of this interdisciplinary field. This approval signifies a new phase in the construction of BCI disciplines and talent cultivation in China, aligning with national strategic goals. The establishment of this doctoral program complements Tianjin University's plans for a comprehensive educational pathway in BCI, which includes the launch of the country's first undergraduate program in BCI in 2024. This initiative aims to create a full talent development system from undergraduate to doctoral levels, addressing the interdisciplinary nature of BCI that integrates clinical medicine, neuroscience, artificial intelligence, and electronic information. Looking ahead, the university plans to leverage this doctoral program to develop a complete technical chain in BCI, focusing on devices, chips, algorithms, and applications. The success of this interdisciplinary training model will depend on the integration of curriculum, mentorship, and industry practice, as the demand for skilled professionals in the rapidly growing BCI market is expected to surge significantly by 2040.
Brain-Computer Interface Interdisciplinary Studies Artificial Intelligence Neuroscience Education
Over 200 Brain-Computer Interface Companies Established, Yet Experts Highlight Key Challenges
At the Boao Forum for Asia Global Health Forum on September 15, Zuo Nianming, a researcher at the Institute of Automation of the Chinese Academy of Sciences, stated that brain-computer interfaces (BCIs) could empower 10% to 15% of those requiring medical resources. However, he outlined four significant challenges: inconvenience, instability, lack of intelligence, and non-necessity. These issues highlight the gap between the increasing number of BCI companies and the actual usability of the technology in real-world scenarios. Despite the rapid growth of the BCI sector, with over 200 companies in China and a projected market size of 120 billion yuan by 2040, experts emphasize that the technology has not yet reached maturity. Tao Hu, founder and chief scientist of Shanghai Brain Tiger Technology, noted that while research is driven by interest, industry success hinges on meeting system-level and product-level demands. The focus should be on addressing real patient needs rather than merely technological capabilities. Regulatory frameworks are being developed to ensure the safety and efficacy of BCIs, with attention to aspects like biocompatibility and signal processing. Zuo Nianming identified three evolution directions for BCIs: healthcare, natural interaction, and brain-computer intelligence. While healthcare represents the strongest immediate need, significant public education is required to clarify the boundaries of BCI technology. Currently, there is a mismatch between policy-driven growth and the actual technological readiness to meet real-world demands.
Brain-Computer Interfaces Medical Technology Regulatory Standards Healthcare Innovation
Paradromics Enables Communication for Woman with Severe Speech Impairment Using Brain-Computer Interface
Paradromics has announced a breakthrough in brain-computer interface technology, allowing a woman with severe speech impairment to communicate freely. The participant, a woman in her 60s from Michigan suffering from progressive motor neuron disease, had the Connexus system implanted, which features over 400 electrodes to capture neural activity at a single-neuron level. This advancement is significant as it enables the user to express her thoughts and engage in real-time conversations, rather than merely completing predefined tasks. The first sentence she communicated was 'Okay, I have a lot to say,' demonstrating the system's ability to decode spontaneous speech accurately without prior preparation. Looking ahead, Paradromics plans to recruit 10 patients with speech and motor paralysis due to conditions like stroke and ALS for further studies. The results from the initial participant are promising, but the broader applicability of the system remains to be validated with additional participants in future trials.
Brain-Computer Interfaces Neural Communication Assistive Technology Speech Decoding
New Era for Brain-Computer Interface IPOs as Companies Enter Capital Market
In September 2026, Shuli Innovation completed its IPO counseling filing on the Sci-Tech Innovation Board, marking its entry into the brain-computer interface (BCI) IPO race. Previously, Borui Kang's IPO application was accepted, and Qiangnao Technology reportedly submitted a confidential application for the Hong Kong stock market. The question of which company will become the first BCI stock remains a focal point in the industry. The capital market is shifting its focus from merely advanced technology to practical applications of BCIs. Companies must now address critical questions such as hospital procurement, physician usage, patient acceptance, and payment systems. This shift indicates that the competition is evolving from technical specifications to clinical data, product registration, and application scenarios. The 2026 IPO wave reflects this transformation, as the market helps identify companies with both strong technological vision and practical implementation capabilities. Shuli Innovation, founded in 2015, focuses on non-invasive BCIs aimed at rehabilitation for patients with motor function impairments, emphasizing the restoration of the connection between the brain and body rather than enhancing abilities in healthy individuals.
Brain-Computer Interfaces Healthcare Technology Medical Devices Clinical Applications
Science Corporation's Retina Chip Receives CE Certification, Pioneering Brain-Computer Interface Advances
In July 2026, Science Corporation's retinal chip achieved CE certification in the EU, marking a significant milestone in brain-computer interface commercialization. While Neuralink continues to address safety concerns for human trials, Science Corporation, founded by a former co-founder, is set to launch its first commercial implants in Germany. This development is crucial as it signifies a shift from theoretical concepts of brain-computer interfaces to practical medical applications. The Prima retinal chip, measuring just 2x2 mm and powered by near-infrared light through smart glasses, has shown promising clinical results, with 84% of patients recovering reading abilities. Looking ahead, 2026 is anticipated to be a pivotal year for brain-computer interfaces, with regulatory frameworks being established in China and significant advancements in both invasive and non-invasive devices. Science Corporation aims to complete dozens of commercial implants this year and targets around 200 next year, with revenue from the Prima chip expected to fund the development of next-generation neural interfaces.
Brain-Computer Interfaces Medical Devices Neurotechnology Clinical Applications
Shanghai Startup LeapTech Develops Brain-Computer Interface for Stress Relief, Secures Funding
LeapTech, a startup from Shanghai, has developed a brain-computer interface (BCI) aimed at stress relief and has recently completed a seed funding round of nearly 10 million yuan. The funding, provided by angel investors with expertise in hard technology, consumer electronics, and manufacturing, will support the iteration of a non-invasive wearable BCI, the refinement of neural feedback algorithms, and the establishment of a production supply chain. Founded in October 2025 by Sun Huihua, a PhD from Shanghai Jiao Tong University, LeapTech focuses on consumer-grade BCI products that manage mental order, brain stability, and emotional energy. The non-invasive device collects EEG signals in real-time and intervenes acoustically when it detects stress or anxiety, guiding users into states of relaxation, meditation, focus, or sleep. Looking ahead, LeapTech plans to launch several wearable BCI products targeting relaxation, menstrual comfort, and energy maintenance. The company also aims to provide EEG collection hardware and acoustic solutions for smart headphones and wellness brands. As BCIs transition from medical devices to everyday consumer electronics, LeapTech seeks to address the challenge of maintaining mental well-being in an information-saturated world. No further timeline was disclosed at the time of publication.
Brain-Computer Interfaces Mental Health Technology Wearable Devices AI Solutions
Haier Collaborates with Tianjin University to Create Brain-Computer Interface Model Ward
On August 15, Haier Group's health brand, YK Life, signed a strategic cooperation agreement with Tianjin University's Brain-Computer Interaction Laboratory in Qingdao. This partnership aims to establish a model ward for brain-computer interfaces, focusing on clinical trials and technology validation for neurological rehabilitation and brain disease treatment. This initiative is significant as it transforms a real hospital into a testing ground for advanced technology, addressing the bottleneck of clinical application in brain-computer interface development. The collaboration will leverage clinical scenarios from YK Life's hospitals and the 'Haiyihui' platform to explore replicable and scalable pathways for technology validation. Looking ahead, both parties will also establish a special industrial fund for brain-computer interfaces to support innovation and project incubation. The establishment of this model ward marks a crucial step towards realizing the potential of brain-computer interfaces, bringing the technology closer to practical applications in patient care.
Brain-Computer Interfaces Healthcare Technology Neuroscience Clinical Trials
300 Million People Face Sleep Issues: The Role of Brain-Computer Interfaces
A significant number of individuals struggle with sleep, with nearly 300 million people in China alone affected by insomnia, according to the 2025 China Sleep Health Survey Report. Traditional sleep aids have focused on monitoring sleep quality rather than addressing the underlying neurological issues that prevent restful sleep. Brain-computer interface (BCI) companies are emerging with innovative products such as headbands, pillows, and sleep pods that aim to directly influence brain activity. These devices read brain waves and utilize microcurrents or sound waves to promote sleep, moving beyond mere tracking of sleep patterns. The global sleep economy is projected to approach $600 billion by 2025, with a significant portion dedicated to diagnosing and treating sleep disorders. As the market for portable sleep monitoring devices grows, it is essential to watch how BCI technology will evolve and potentially transform the landscape of sleep solutions.
Brain-Computer Interfaces Sleep Technology Health Tech Consumer Electronics
CorTec Secures Second FDA Breakthrough Device Designation for Brain Interchange BCI
CorTec has achieved a second Breakthrough Device Designation from the FDA for its Brain Interchange brain-computer interface, specifically for aiding communication in individuals with non-progressive quadriplegia. This designation allows users with paralysis in all four limbs to control a computer cursor using neural signals, facilitating independent interaction with digital systems. This development is significant as it highlights the potential of the Brain Interchange platform to serve dual purposes: as a therapeutic tool for stroke rehabilitation and as an assistive device for communication. The FDA's Breakthrough Device Designation is granted to technologies that promise more effective treatment for serious conditions, ensuring a streamlined regulatory review process. Looking ahead, CorTec is set to explore the communication capabilities of the Brain Interchange system under structured FDA engagement. The ongoing stroke study at the University of Washington has already shown promising results, with participants demonstrating computer control through thought, indicating the system's potential for enhancing the quality of life for individuals with severe mobility impairments.
Computing Health News Science bci brain interchange
Chengdu's Brain-Machine Interface Strategy Focuses on Collaboration Rather Than Subsidies
As of May this year, the number of subjects for implanted brain-machine interfaces globally stands at only 107 to 110. Meanwhile, domestic financing for brain-machine interfaces exceeded 60 instances in the first half of the year, totaling over 7 billion yuan. This ratio highlights that funding does not equate to immediate clinical progress but rather future entry qualifications. Shanghai BoRuiKang received the world's first registration certificate for invasive brain-machine interfaces in March, with 36 implants and a cumulative safety record of over 14,000 days. In April, Beijing's 'BeiNai No. 1' semi-invasive system completed its first live surgery, achieving a motion intention decoding latency of less than 100 milliseconds. Chengdu's Ximang Medical has established its headquarters, and Gestalt Technology's ultrasound brain-machine interface factory began operations in June, although these companies have yet to present clinical data. Chengdu's strategy differs from Shanghai and Beijing by emphasizing daily interactions between doctors and engineers rather than merely obtaining certifications. The Western Brain Valley, a specialized building for brain-machine interfaces, has achieved a 100% occupancy rate within six months. However, no companies in Chengdu have yet received registration certificates or reported any implant surgeries, indicating that while the infrastructure is in place, clinical data remains absent.
Brain-Machine Interfaces Medical Technology Clinical Research Healthcare Innovation
First Brain-Machine Interface Medical Device Approved, Paving the Way for Clinical Use
On March 13, 2023, Biorikon's implantable brain-machine interface hand function compensation system received approval from the National Medical Products Administration, marking it as the first approved implantable brain-machine interface medical device globally. This advancement enables paralyzed patients to control external devices through brain signals, transitioning technology from experimental validation to real-world application. The significance of this approval lies in its potential to overcome critical hurdles for medical technologies, such as regulatory approval and clinical evidence requirements. Biorikon's system, which includes components like implanted electrodes and decoding software, aims to assist patients with specific spinal cord injuries in regaining hand function. This clarity in product boundaries is crucial as the industry moves towards integrating brain-machine interfaces into therapeutic practices. Following the approval, Huashan Hospital issued the first clinical prescription for the device and completed its first implantation. This milestone illustrates the pathway from registration to clinical application, showcasing a structured approach that has previously been seen only in established medical devices. The successful integration of this technology into treatment protocols will be closely monitored in the coming months.
Brain-Machine Interfaces Medical Devices Clinical Trials Neurotechnology
First Computer Vision-Guided Surgery Successfully Removes Brain Tumor While Preserving Vision
A neurosurgeon at the National Hospital for Neurology and Neurosurgery in London successfully performed the world's first computer vision-guided brain surgery, aided by a real-time machine intelligence system. This innovative technology helped remove a pituitary tumor from 48-year-old Rhys Hibbert without compromising his eyesight, a significant achievement in neurosurgery. The procedure highlights the importance of integrating advanced technologies in delicate surgical environments, particularly in pituitary surgeries where proximity to critical structures like optic nerves poses high risks. The software, developed at University College London, processed live video feeds to identify critical anatomy, providing surgeons with real-time visual references during the operation. Looking ahead, the technology, which runs on NVIDIA’s Clara IGX platform, aims to evolve beyond anatomy recognition to potentially track surgical instruments and their interactions with tissue. This advancement could enhance surgical precision and safety in future procedures. No further timeline was disclosed at the time of publication.
AI and Robotics Health
Chinese Startup StairMed Develops 'Injection-Level' Brain-Machine Interface Chip
StairMed Technology, a Shanghai-based startup, has developed a novel brain-machine interface (BCI) implantation method that reduces the procedure time from two hours to approximately ten minutes. Unlike traditional open-brain surgeries, this system utilizes a catheter that enters through the neck vein, reaching the target area in the brain without the need to open the skull. This innovation is significant as it transforms the BCI implantation process from a complex neurosurgical operation into an outpatient procedure. Dr. Duan Wanru from Xuanwu Hospital noted that a surgeon with 4 to 5 years of experience could complete the procedure in just ten minutes. StairMed's ultra-flexible electrode, measuring only 1 micron in diameter, is designed to penetrate the blood vessel wall and make direct contact with brain tissue, differing from similar technologies that keep electrodes inside the vessel. StairMed has raised over 1.1 billion RMB (approximately $163 million) in funding over the past year, with major investors including Tencent and Alibaba. While the technology has been tested in sheep, human clinical trials have not yet commenced. If successful, StairMed's ten-minute implantation could revolutionize the pathway for BCIs from laboratory settings to clinical applications.
Brain-Machine Interfaces Medical Technology Neurosurgery Healthcare Innovation
Former OpenAI Researcher Joins Conduit to Develop Non-Invasive Brain-Machine Interface
On August 6, Naomi Bashkansky, a 23-year-old former OpenAI researcher, announced her new role at the startup Conduit, just two weeks after leaving OpenAI. As a founding researcher, she will focus on developing a non-invasive brain-machine interface that translates thoughts into text without the need for surgery or implanted electrodes. This innovative approach aims to capture the semantic intent of individuals before they verbally express or type their thoughts, potentially revolutionizing human-computer interaction. The vision of Conduit is ambitious, with many research questions still in a 'greenfield' state, allowing Bashkansky to engage deeply in data collection and model training. Founded in 2024 in San Francisco, Conduit has a small core team, including co-founders Rio Popper and Clem von Stengel, who bring unique perspectives on human-computer interaction and AI. As the company progresses, the integration of brain signals with AI technology will be a key area to watch.
Brain-Machine Interfaces Neural Decoding AI Technology Startups
Significant Milestones in Brain-Machine Interfaces for Motor Rehabilitation in 2026
In 2026, a pivotal milestone was reached in China's brain-machine interface (BMI) clinical research with the release of a comprehensive report detailing current advancements, clinical applications, and future prospects. This report serves as a systematic overview of the past year's research achievements and outlines a clear pathway for transitioning BMI technology from the laboratory to clinical settings. The most notable finding is the substantial breakthroughs in applying BMI technology for rehabilitation in patients with motor function disorders. Clinical interventions on multiple hemiplegic patients revealed that non-invasive BMI rehabilitation training systems significantly accelerated the recovery of motor functions, outperforming traditional rehabilitation methods. This advancement indicates that 'thought control,' once a concept of science fiction, is becoming a viable medical solution. Technological progress is equally impressive, with new high signal-to-noise ratio signal acquisition devices and deep learning decoding algorithms enhancing the stability and practicality of BMI systems. Users can start using the systems without complex calibration, and interaction delays have been reduced to milliseconds, crucial for real-time feedback in rehabilitation. With the establishment of ethical norms and regulatory frameworks, the path for clinical applications of BMIs has been cleared, paving the way for widespread adoption in the next five years.
Brain-Machine Interfaces Neurorehabilitation Clinical Research Medical Technology
BrainCo Unveils First Brain-Machine Interface for Controlling Robots at WAIC 2026
At the 2026 World Artificial Intelligence Conference (WAIC), BrainCo launched the world's first brain-controlled robot AI platform. This innovative system utilizes a non-invasive electroencephalogram (EEG) headset to convert human neural activity into executable commands for robots in real-time. The significance of this technology lies in its potential to revolutionize human-robot interaction. By simply thinking about an action, users can control robots to perform tasks such as grabbing or moving objects without verbal commands or button presses. BrainCo's platform is designed to create a 'human-machine co-training' data loop, which will gather extensive data from users to enhance AI's physical world interactions. Looking ahead, BrainCo's brain-machine interface could mark the beginning of a new era in human-robot collaboration. As users engage with the system, the feedback and data collected will be invaluable for refining AI algorithms and improving the overall user experience. No further timeline was disclosed at the time of publication.
Brain-Machine Interface Robotics Artificial Intelligence EEG Technology
Brain-Computer Interfaces and Humanoid Robots: The Next Frontier in Robotics?
Beijing Hangnao Technology has entered into a strategic partnership with EXROBOT to develop humanoid robots equipped with brain-computer interface technology. This collaboration, announced recently, aims to create machines capable of emotional interaction, marking a shift from traditional industrial applications to a focus on emotional understanding. Both companies acknowledge the significant technical challenges that lie ahead as they explore this innovative technological frontier.
Brain-Computer Interfaces Humanoid Robots Emotional Interaction AI Technology
Brain-Computer Interfaces: The Next Cheating Tool After Smart Glasses?
As the 2026 college entrance exam in China draws near, authorities are increasingly concerned about the potential use of smart glasses as cheating devices. In response, several regions have issued warnings prohibiting the wearing or bringing of such technology into exam venues. This move underscores the ongoing challenges related to exam security in an era of rapidly advancing technology. Additionally, while brain-computer interfaces (BCIs) have not yet emerged as a practical tool for cheating, their development prompts significant ethical considerations regarding the intersection of technology and education.
Brain-Computer Interfaces Exam Security Educational Technology Cheating Prevention
Neuralink Advances Brain-Computer Interface with Specialized Surgical Robot and Fully Automated Implantation
Neuralink has introduced a cutting-edge surgical robot designed to automate the implantation of brain-computer interfaces, a significant advancement in neurosurgery. This innovative technology addresses the complex challenge of implanting devices without the need to remove the dura mater, the protective layer surrounding the brain. The company aims to achieve mass production of this robotic system by 2026, with the goal of improving the precision and safety of surgeries for individuals suffering from paralysis and vision impairments. This development marks a crucial step forward in the integration of advanced robotics in medical procedures, potentially transforming the treatment landscape for patients with neurological conditions.
Brain-Computer Interfaces Surgical Robotics Neurotechnology Medical Devices
Overview of China's Brain-Computer Interface Policies: A Clear Roadmap
China is making significant strides in the development and commercialization of brain-computer interface (BCI) technology, as outlined in a recent analysis of the country's evolving policies. The article details the strategic phases of BCI policy, which encompass foundational research, ethical guidelines, and various industry applications. This comprehensive approach reflects China's ambition to lead in this cutting-edge field. By establishing a robust framework for BCI development, the nation aims to harness the potential of this technology for both scientific advancement and practical use. As the global landscape of BCI continues to evolve, China's proactive stance positions it as a key player in shaping the future of this innovative sector.
Brain-Computer Interfaces Neuroscience Medical Technology AI Policy Development
Humanity Enters the Era of Brain-Computer Interfaces
Nolan Abbot has become the first individual to receive a Neuralink chip, showcasing a remarkable advancement in brain-computer interface (BCI) technology. This milestone, achieved recently, allows Abbot to control devices using only his thoughts, representing a significant breakthrough in the field. The development of BCIs is increasingly seen as crucial for national strategy and global competition, highlighting the urgency for innovation in this area. As researchers and companies race to enhance these technologies, the implications for communication, accessibility, and human-computer interaction are profound, potentially transforming how individuals engage with the digital world.
Brain-Computer Interfaces Neural Technology Medical Innovation Assistive Technology
NueroDance Introduces ND1000 and ND8 EEG Devices Alongside NeuroAI Data Platform
NueroDance has launched its ND1000 and ND8 series EEG devices, along with the NeuroAI group cross-modal data platform, during an event in Beijing. This initiative aims to establish a neural data infrastructure that extends the capabilities of AI beyond traditional text and image processing. The introduction of these EEG devices and the NeuroAI platform signifies a strategic move by NueroDance to position itself at the forefront of the evolving AI landscape. By focusing on cross-modal data, the company seeks to unlock new applications and insights from neural data, potentially transforming how AI systems interact with human cognitive processes. As the demand for advanced AI solutions grows, the development of a robust neural data infrastructure will be crucial. Observers should watch for how NueroDance's offerings will influence the AI sector and whether they can successfully integrate brain-computer hardware with multi-scene neural data applications. No further timeline was disclosed at the time of publication.
Technology
West Lake University Spin-off Secures Millions for Brain-Machine Interface Focused on Chinese Language Decoding
A brain-machine interface company, incubated by West Lake University, has successfully secured tens of millions in funding to advance its development of chips and decoding technology designed to assist individuals with speech impairments in communicating in Chinese. This innovative initiative focuses on translating brain signals into text and speech, specifically accommodating the tonal nuances of the Chinese language. The funding marks a significant milestone in the evolution of assistive communication technology, aiming to enhance the quality of life for those facing communication challenges.
Brain-Machine Interfaces Speech Technology Neural Decoding Assistive Technology
4 Billion in Investment Floods into the Brain-Machine Interface Sector
In the first quarter of 2026, the brain-machine interface sector experienced a remarkable surge in funding, attracting over 4 billion yuan, a figure that exceeds the total investments for the entire year of 2025. This rapid growth is being driven by key industry players, including Qiangnao Technology and Jieti Medical, who are making substantial strides in both invasive and non-invasive technologies. The influx of capital reflects a growing interest and confidence in the potential applications of brain-machine interfaces, which are poised to revolutionize fields such as healthcare and communication. As these companies continue to innovate and expand their offerings, the sector is set to play a pivotal role in shaping the future of technology and human interaction.
Brain-Machine Interfaces Medical Technology Investment Trends NeurotechnologyRobotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
